<?xml version="1.0" encoding="UTF-8"?>
<p>According to Singh et al. [
 <xref rid="B185-pharmaceutics-12-00171" ref-type="bibr">185</xref>] review from 2017 and also to available information on the respective websites there are still several nanomedicines under evaluation, namely:
 <list list-type="bullet">
  <list-item>
   <p>Fluquit (STP 702) from Sirnaomics Inc. currently under preclinical evaluation, a polymer-based nanotherapeutic that incorporates siRNA and targeting the H5N1 (avian flu), H1N1 (swine flu) influenza, and newly emerging H7N9; and cervisil (STP909), a nanobased drug candidate, which incorporates siRNA for the treatment of HPV16 and HPV18;</p>
  </list-item>
  <list-item>
   <p>DermaVir from Genetic Immunity, a synthetic pathogen-like nanomedicine that incorporates single plasmid DNA expressing 15 HIV antigens that assemble to HIV-like particles; DermaVir vaccine completed Phase I/II randomized, placebo-controlled, dose-finding, double-blinded, multicenter study to assess the safety, tolerability and immune response in HIV-1-infected adults who are currently receiving anti-HIV treatment (number NCT00270205) [
    <xref rid="B194-pharmaceutics-12-00171" ref-type="bibr">194</xref>];
   </p>
  </list-item>
  <list-item>
   <p>Doravirine (MK-1439), from Merck, a novel, next generation NNRTI described as solid drug nanoparticle formulation tested for HIV; currently doravirine completed the pharmacokinetic trial of the bioavailability of four MK-1439 nano formulations in healthy adults (number NCT02549040) [
    <xref rid="B195-pharmaceutics-12-00171" ref-type="bibr">195</xref>];
   </p>
  </list-item>
  <list-item>
   <p>Lipid nanoparticles of ARB-001467 TKM-HBV containing three RNAi therapeutics for HBV genome targeting from Arbutus Biopharma; in 2018 the company completed the phase 2a, single blind, randomized, placebo controlled, study evaluating the safety, anti-viral activity, and pharmacokinetics (PK) following multiple doses of intravenous ARB-001467 (number NCT02631096) [
    <xref rid="B196-pharmaceutics-12-00171" ref-type="bibr">196</xref>].
   </p>
  </list-item>
 </list>
</p>
